Literature DB >> 32703400

CRL4DCAF8 and USP11 oppositely regulate the stability of myeloid leukemia factors (MLFs).

Daoyuan Huang1, Cheng Liu1, Xiwen Sun1, Xinpei Sun1, Yanan Qu1, Yunyi Tang1, Guodong Li1, Tanjun Tong2.   

Abstract

Myeloid leukemia factors (MLF1 and MLF2) are proteins associated with leukemia and several other cancers. However, little is known about the regulatory mechanisms underlying the stability of these proteins. Here, we show that DDB1 and CUL4 associated factor 8 (DCAF8), which can form a functional E3 ligase complex (CRL4DCAF8), has a strong interaction with the MLF2 protein. DCAF8 could promote MLF2 degradation through the ubiquitin-proteasome pathway. In contrast, ubiquitin specific peptidase 11 (USP11) associates with MLF2, thereby increasing its stability. Since MLF1 is highly related to MLF2, we demonstrated that MLF1 also interacts with DCAF8 and USP11, suggesting that CRL4DCAF8 and USP11 may also regulate the expression of MLF1. TCGA analysis revealed that both the myeloid leukemia factors (MLF1 and MLF2) show significant differential expression in various tumors. The results of our study indicate that CRL4DCAF8 and USP11 play opposite roles in the regulation of MLF1 and MLF2, which may, in turn, affect their biological functions in various cancers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DCAF8; MLF1; MLF2; Protein degradation; USP11

Year:  2020        PMID: 32703400     DOI: 10.1016/j.bbrc.2020.05.186

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesis.

Authors:  Xiuli Zhang; Zhizhou Xia; Xingyu Lv; Donghe Li; Mingzhu Liu; Ruihong Zhang; Tong Ji; Ping Liu; Ruibao Ren
Journal:  Front Med       Date:  2021-04-14       Impact factor: 4.592

Review 2.  The Dual Role of USP11 in Cancer.

Authors:  Tuanjie Guo; Heting Tang; Zhihao Yuan; Encheng Zhang; Xiang Wang
Journal:  J Oncol       Date:  2022-03-22       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.